Corrigendum: Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease (Scientific Reports (2015) 4:7190 Doi:10.1038/srep07190);Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Lee, Linda ^a,b   Dale, Elena ^a   Staniszewski, Agnes ^a   Zhang, Hong ^a   Saeed, Faisal ^a   Sakurai, Mikako ^a   Fa', Mauro ^a   Orozco, Ian ^a   Michelassi, Francesco ^a   Akpan, Nsikan ^a   Lehrer, Helaina ^b   Arancio, Ottavio ^a  

^a NewYork Presbyterian Hospital   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; SUMO 1 PROTEIN;

AGED; ALZHEIMER DISEASE; ANIMAL; C57BL MOUSE; COGNITION; DISEASE MODEL; HIPPOCAMPUS; HUMAN; LONG TERM POTENTIATION; MALE; MEMORY; METABOLISM; MIDDLE AGED; MOUSE; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SUMOYLATION; TRANSGENIC MOUSE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; COGNITION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; LONG-TERM POTENTIATION; MALE; MEMORY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; NEURONAL PLASTICITY; SUMO-1 PROTEIN; SUMOYLATION;

EID: 84934958460     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11782     Document Type: Erratum

References (79)

1. Soderling, T. R. & Derkach, V. A. Postsynaptic protein phosphorylation and LTP. Trends Neurosci. 23, 75-80 (2000).
2. DiAntonio, A. & Hicke, L. Ubiquitin-dependent regulation of the synapse. Annu. Rev. Neurosci. 27, 223-246 (2004).
3. Fukata, Y. & Fukata, M. Protein palmitoylation in neuronal development and synaptic plasticity. Nat. Rev. Neurosci. 11, 161-175 (2010).
4. Routtenberg, A. & Rekart, J. L. Post-translational protein modification as the substrate for long-lasting memory. Trends Neurosci. 28, 12-19 (2005).
5. Lee, V. M., Goedert, M. & Trojanowski, J. Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159 (2001).
6. Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nat. Med. 10 Suppl, S10-17 (2004).
7. Snyder, E. M. et al. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 1051-1058 (2005).
8. Hsieh, H. et al. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831-843 (2006).
9. Martin, S., Wilkinson, K. A., Nishimune, A. & Henley, J. M. Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat. Rev. Neurosci. 8, 948-959 (2007).
10. Geiss-Friedlander, R. & Melchior, F. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell Biol. 8, 947-956 (2007).
11. Johnson, E. S. Protein modification by SUMO. Annu. Rev. Biochem. 73, 355-382 (2004).
12. Zhang, F. P. et al. Sumo-1 function is dispensable in normal mouse development. Mol. Cell. Biol. 28, 5381-5390 (2008).
13. Lee, Y. J. et al. Elevated Global SUMOylation in Ubc9 Transgenic Mice Protects Their Brains against Focal Cerebral Ischemic Damage. PloS one 6, e25852 (2011).
14. Watanabe, M., Takahashi, K., Tomizawa, K., Mizusawa, H. & Takahashi, H. Developmental regulation of Ubc9 in the rat nervous system. Acta Biochim. Pol. 55, 681-686 (2008).
15. Wilkinson, K. A., Nakamura, Y. & Henley, J. M. Targets and consequences of protein SUMOylation in neurons. Brain Res. Rev. 64, 195-212 (2010).
16. Martin, S., Nishimune, A., Mellor, J. R. & Henley, J. M. SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 447, 321-325 (2007).
17. Feligioni, M., Nishimune, A. & Henley, J. M. Protein SUMOylation modulates calcium influx and glutamate release from presynaptic terminals. Eur. J. Neurosci. 29, 1348-1356 (2009).
18. Fleck, M. W., Palmer, A. M. & Barrionuevo, G. Potassium-induced long-term potentiation in rat hippocampal slices. Brain Res. 580, 100-105 (1992).
19. Baron, C., Benes, C., Van Tan, H., Fagard, R. & Roisin, M. P. Potassium chloride pulse enhances mitogen-activated protein kinase activity in rat hippocampal slices. J. Neurochem. 66, 1005-1010 (1996).
20. Saitoh, H. & Hinchey, J. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275, 6252-6258 (2000).
21. Johnson, E. S. & Gupta, A. A. An E3-like factor that promotes SUMO conjugation to the yeast septins. Cell 106, 735-744 (2001).
22. Tatham, M. H. et al. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10, 538-546 (2008).
23. Tatham,M.H. et al. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276, 35368-35374 (2001).
24. Lopantsev, V., Both, M. & Draguhn, A. Rapid plasticity at inhibitory and excitatory synapses in the hippocampus induced by ictal epileptiform discharges. Eur. J. Neurosci. 29, 1153-1164 (2009).
25. Ludvig, N., Chao, K., Altura, B. T., Altura, B. M. & Fox, S. E. Manipulation of pyramidal cell firing in the hippocampus of freely behaving rats by local application of K1 via microdialysis. Hippocampus 6, 97-108 (1996).
26. Craig, T. J. et al. Homeostatic synaptic scaling is regulated by protein SUMOylation. J. Biol. Chem. (2012).
27. Gong, B. et al. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775-788 (2006).
28. Gump, J. M. & Dowdy, S. F. TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol. Med. 13, 443-448 (2007).
29. Gong, L., Kamitani, T., Fujise, K., Caskey, L. S.&Yeh, E. T. Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9. J. Biol. Chem. 272, 28198-28201 (1997).
30. Xhemalce, B. et al. Role of SUMO in the dynamics of telomere maintenance in fission yeast. Proc Natl Acad Sci U S A 104, 893-898 (2007).
31. Buschmann, T., Lerner, D., Lee, C. G. & Ronai, Z. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9. J. Biol. Chem. 276, 40389-40395 (2001).
32. Mukhopadhyay, D. & Dasso, M. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32, 286-295 (2007).
33. Bailey, D.&O'Hare, P. Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J. Biol. Chem. 279, 692-703 (2004).
34. Barad, M., Bourtchouladze, R.,Winder, D. G., Golan, H. & Kandel, E. Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of longlasting long-term potentiation and improves memory. Proc Natl Acad Sci U S A 95, 15020-15025 (1998).
35. Lambert, M. P. et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95, 6448-6453 (1998).
36. Busciglio, J., Lorenzo, A., Yeh, J. & Yankner, B. A. beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888 (1995).
37. Williamson, R. et al. Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases. J. Neurosci. 22, 10-20 (2002).
38. Hsiao, K. et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102 (1996).
39. Westerman, M. A. et al. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22, 1858-1867 (2002).
40. Barnes, P. & Good, M. Impaired Pavlovian cued fear conditioning in Tg2576 mice expressing a human mutant amyloid precursor protein gene. Behav. Brain Res. 157, 107-117 (2005).
41. Li, Y. et al. Positive and negative regulation of APP amyloidogenesis by sumoylation. Proc Natl Acad Sci U S A 100, 259-264 (2003).
42. Dorval, V.,Mazzella, M. J., Mathews, P. M., Hay, R. T. & Fraser, P. E. Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins. Biochem. J. 404, 309-316 (2007).
43. Zhang, Y. Q. & Sarge, K. D. Sumoylation of amyloid precursor protein negatively regulates Abeta aggregate levels. Biochem. Biophys. Res. Commun. 374, 673-678 (2008).
44. Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101-112 (2007).
45. Loriol, C., Khayachi, A., Poupon, G., Gwizdek, C. &Martin, S. Activity-dependent regulation of the sumoylation machinery in rat hippocampal neurons. Biol. Cell 105, 30-45 (2013).
46. Jaafari, N. et al. SUMOylation Is Required for Glycine-Induced Increases in AMPA Receptor Surface Expression (ChemLTP) in Hippocampal Neurons. PLoS One 8, e52345 (2013).
47. Rosas-Acosta, G., Russell, W. K., Deyrieux, A., Russell, D. H. & Wilson, V. G. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol. Cell. Proteomics 4, 56-72 (2005).
48. Vertegaal, A. C. et al. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell. Proteomics 5, 2298-2310 (2006).
49. Ayaydin, F. & Dasso, M. Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol Biol Cell 15, 5208-5218 (2004).
50. Shen, L. N.,Geoffroy, M. C., Jaffray, E. G. &Hay, R. T. Characterization of SENP7, a SUMO-2/3-specific isopeptidase. Biochem. J. 421, 223-230 (2009).
51. Klann, E., Chen, S. J. & Sweatt, J. D. Persistent protein kinase activation in the maintenance phase of long-term potentiation. J. Biol. Chem. 266, 24253-24256 (1991).
52. Klann, E., Chen, S. J. & Sweatt, J. D. Increased phosphorylation of a 17-kDa protein kinase C substrate (P17) in long-term potentiation. J. Neurochem. 58, 1576-1579 (1992).
53. Siciliano, J. C., Gelman,M. & Girault, J. A. Depolarization and neurotransmitters increase neuronal protein tyrosine phosphorylation. J. Neurochem. 62, 950-959 (1994).
54. Rosenblum, K., Dudai, Y. & Richter-Levin, G. Long-term potentiation increases tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit 2B in rat dentate gyrus in vivo. Proc Natl Acad Sci U S A 93, 10457-10460 (1996).
55. Rostas, J. A. et al. Enhanced tyrosine phosphorylation of the 2B subunit of the Nmethyl-D-aspartate receptor in long-term potentiation. Proc Natl Acad Sci U S A 93, 10452-10456 (1996).
56. Akers, R. F., Lovinger, D. M., Colley, P. A., Linden, D. J. & Routtenberg, A. Translocation of protein kinase C activity may mediate hippocampal long-term potentiation. Science 231, 587-589 (1986).
57. Sweatt, J. D. & Kandel, E. R. Persistent and transcriptionally-dependent increase in protein phosphorylation in long-term facilitation of Aplysia sensory neurons. Nature 339, 51-54 (1989).
58. Lovinger, D. M.,Wong, K. L., Murakami, K. & Routtenberg, A. Protein kinase C inhibitors eliminate hippocampal long-term potentiation. Brain Res. 436, 177-183 (1987).
59. Malinow, R., Madison, D. V. & Tsien, R. W. Persistent protein kinase activity underlying long-term potentiation. Nature 335, 820-824 (1988).
60. Malenka, R. C. et al. An essential role for postsynaptic calmodulin and protein kinase activity in long-term potentiation. Nature 340, 554-557 (1989).
61. Schafe, G. E., Nadel, N. V., Sullivan, G. M., Harris, A. & LeDoux, J. E. Memory consolidation for contextual and auditory fear conditioning is dependent on protein synthesis, PKA, and MAP kinase. Learn Mem 6, 97-110 (1999).
62. Blum, S., Moore, A. N., Adams, F. & Dash, P. K. A mitogen-activated protein kinase cascade in the CA1/CA2 subfield of the dorsal hippocampus is essential for long-term spatial memory. J. Neurosci. 19, 3535-3544 (1999).
63. Chamberlain, S. E. et al. SUMOylation and phosphorylation of GluK2 regulate kainate receptor trafficking and synaptic plasticity. Nat. Neurosci. 15, 845-852 (2012).
64. Sarge, K. D. & Park-Sarge, O. K. Sumoylation and human disease pathogenesis. Trends Biochem. Sci. 34, 200-205 (2009).
65. Steffan, J. S. et al. SUMO modification of Huntingtin and Huntington's disease pathology. Science 304, 100-104 (2004).
66. McMillan, L. E., Brown, J. T., Henley, J. M. & Cimarosti, H. Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model. Neurosci. Lett. 502, 201-208 (2011).
67. Nistico, R. et al. Age-related changes of protein SUMOylation balance in the AbetaPP Tg2576 mouse model of Alzheimer's disease. Frontiers in pharmacology 5, 63 (2014).
68. Ahn, K. et al. Ubc9 gene polymorphisms and late-onset Alzheimer's disease in the Korean population: a genetic association study. Neurosci. Lett. 465, 272-275 (2009).
69. Grupe, A. et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Hum. Mol. Genet. 16, 865-873 (2007).
70. Corneveaux, J. J. et al. Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum. Mol. Genet. 19, 3295-3301 (2010).
71. Su, Y. F., Yang, T., Huang, H., Liu, L. F. & Hwang, J. Phosphorylation of Ubc9 by Cdk1 enhances SUMOylation activity. PLoS One 7, e34250 (2012).
72. Vincent, I., Jicha, G., Rosado, M. &Dickson, D. W. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci. 17, 3588-3598 (1997).
73. Bowser, R. & Smith, M. A. Cell cycle proteins in Alzheimer's disease: plenty of wheels but no cycle. J Alzheimers Dis 4, 249-254 (2002).
74. Dorval, V. & Fraser, P. E. Small ubiquitin-like modifier (SUMO) modification of natively unfolded proteins tau and alpha-synuclein. J. Biol. Chem. 281, 9919-9924 (2006).
75. Lanz, T. A., Carter, D. B. & Merchant, K. M. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol Dis 13, 246-253 (2003).
76. Jacobsen, J. S. et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 103, 5161-5166 (2006).
77. Dong, H., Martin, M. V., Chambers, S. & Csernansky, J. G. Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice. J. Comp. Neurol. 500, 311-321 (2007).
78. Dahlgren, K. N. et al. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32046-32053 (2002).
79. Puzzo, D. et al. Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J. Neurosci. 28, 14537-14545 (2008).